TACI/TNFRSF13B/CVID Antibody Blocking Peptide
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-76779PEP
Key Product Details
Source
Synthetic
Conjugate
Unconjugated
Applications
Antibody Competition
Product Specifications
Description
A blocking peptide containing 15 amino amino terminus of human TACI.
Source: Synthetic
(Accession #: NP_036584)
Purity
N/A
Application Notes
This peptide is useful as a blocking peptide for NBP1-76779. For further blocking peptide related protocol, click here.
Protein / Peptide Type
Antibody Blocking Peptide
Formulation, Preparation and Storage
NBP1-76779PEP
| Formulation | PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin. |
| Preservative | 0.02% Sodium Azide |
| Concentration | 0.2 mg/ml |
| Shipping | The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Store at -20C. Avoid freeze-thaw cycles. |
Background: TACI/TNFRSF13B
Long Name
Transmembrane Activator and CAML Interactor/Tumor Necrosis Factor Receptor Superfamily Member 13B
Alternate Names
CD267, CVID, TNFRSF13B
Gene Symbol
TNFRSF13B
Additional TACI/TNFRSF13B Products
Product Documents for TACI/TNFRSF13B/CVID Antibody Blocking Peptide
Product Specific Notices for TACI/TNFRSF13B/CVID Antibody Blocking Peptide
This product is for research use only and is not approved for use in humans or in clinical diagnosis. This product is guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...